The price of Boston Scientific Corporation (BSX) on October 9, 2026 is 42.73 USD, +1.64% on the day. Over 52 weeks the stock traded between 41.39 USD and 105.65 USD; the price now sits 2% of the way up that range. Over the past year the price changed by -55.85%. The P/E ratio is 17.4, which is below the sector median (24.8). Market capitalization is 62.10 billion USD, rank 4 among 99 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: 28 October 2026, before market open · Earnings calendar
Boston Scientific Corporation trades on NYSE under the ticker BSX. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks BSX has traded between 41.39 $ and 105.65 $. As of 09 October 2026 the price stood 2.09 % of the way from the 52-week low to the high.
Over one year BSX shares fell 55.85 %; over six months they fell 30.85 %. Volatility over 90 days is 33.17 %. Dividends are not included: this is price change only, as of 09 October 2026.
BSX trades at a price-to-earnings ratio of 17.4, below the sector median of 24.8. Price to sales is 3.0, below the sector median of 3.9. Price to book is 2.4, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 42.12 | 42.83 | 41.97 | 42.73 | 13M |
| 08 October 2026 | 41.50 | 42.27 | 41.39 | 42.04 | 23M |
| 07 October 2026 | 42.19 | 42.52 | 41.50 | 41.58 | 16M |
| 06 October 2026 | 42.47 | 42.75 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Boston Scientific makes devices for minimally invasive procedures — stents, catheters and equipment for treating arrhythmia.
Revenue tracks procedure volume: the more operations performed, the more devices consumed. That makes the business weakly tied to the economic cycle and strongly tied to hospital throughput and staffing.
The main growth line of recent years is treating cardiac rhythm disorders with pulsed electric fields rather than heat. The method is faster and safer for surrounding tissue, and clinics are adopting it at a notable pace.
The company also grows by acquiring smaller developers, which requires continuous investment and adds debt. Risks are litigation over particular products and regulatory requirements for medical devices. It pays no dividend, directing cash into development.
Address:300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234, US
Boston Scientific Corporation reported revenue of 20.6B $ and net income of 3.6B $ over the last four quarters. Net margin is 17.29 %. Revenue changed by +17.43 % year over year. Earnings per share are 2.39 $. Market capitalisation is 62.1B $.
BSX has a return on equity of 13.78 %, above the sector median of −41.68 %. Return on assets is 8.04 %, above the sector median of −32.11 %. Operating margin is 18.40 %, above the sector median of −26.84 %.
| 324M |
| MDLNMedline Inc. | 36.26 | +1.45 % | 297M |
| RMDResMed Inc. | 230.43 | +1.63 % | 276M |
| PODDInsulet Corporation | 135.28 | +0.60 % | 244M |
| WSTWest Pharmaceutical Services, Inc. | 368.78 | +1.52 % | 207M |
| 42.00 |
| 42.19 |
| 13M |
| 05 October 2026 | 42.53 | 43.30 | 42.29 | 42.40 | 14M |
| 02 October 2026 | 43.32 | 43.44 | 41.94 | 42.60 | 18M |
| 01 October 2026 | 43.51 | 43.96 | 42.95 | 43.23 | 18M |
| 30 September 2026 | 43.74 | 43.97 | 43.30 | 43.65 | 18M |
| 29 September 2026 | 44.15 | 44.30 | 43.22 | 43.88 | 15M |
| 28 September 2026 | 43.91 | 44.15 | 43.17 | 44.11 | 22M |
| 25 September 2026 | 44.68 | 44.84 | 43.33 | 43.92 | 15M |
| 24 September 2026 | 44.65 | 45.16 | 44.46 | 44.68 | 17M |
| 23 September 2026 | 45.00 | 45.74 | 43.99 | 44.62 | 19M |
| 22 September 2026 | 44.70 | 45.08 | 44.04 | 44.92 | 21M |
| 21 September 2026 | 42.98 | 43.81 | 42.72 | 43.72 | 25M |
| 18 September 2026 | 43.08 | 43.90 | 43.05 | 43.34 | 29M |
| 17 September 2026 | 43.47 | 43.66 | 42.95 | 43.55 | 33M |
| 16 September 2026 | 43.85 | 44.67 | 43.65 | 43.91 | 28M |
| 15 September 2026 | 44.32 | 44.99 | 43.68 | 43.87 | 16M |
| 14 September 2026 | 44.00 | 45.15 | 43.85 | 45.05 | 21M |